Literature DB >> 1433315

Triacylglycerol metabolism in hypoxic, glucose-deprived rat cardiomyocytes.

T Myrmel1, K Forsdahl, T S Larsen.   

Abstract

We have recently shown that a triacylglycerol (TG)-fatty acid cycle is operating in rat myocardial cells incubated in a hypoxic, glucose-containing incubation medium (Myrmel et al., 1991a). In the present study we investigated whether this cycle occurred in hypoxic, glucose-deprived myocytes, and whether high TG levels would increase TG-fatty acid cycling and thereby energy consumption. Myocytes with elevated contents of TG were obtained from the hearts of streptozotocin-induced diabetic rats (diabetic myocytes) and from normal rat myocytes prepared in the presence of oleic acid (TG-loaded myocytes). The TG content of diabetic and TG-loaded myocytes prior to hypoxic incubations was more than two times higher (P < 0.05) than that of their respective controls (123.8 +/- 20.6 and 125.3 +/- 12.7 vs 56.8 +/- 6.0 and 58.6 +/- 9.4 nmol/10(6) cells, mean +/- S.E., n = 7). Only diabetic and TG-loaded myocytes expressed marked reductions in TG content during glucose free incubations. There were no differences in TG-fatty acid cycling between the various myocyte groups, calculated as the difference between glycerol output and the concomitant decrease in TG (range: 36.7 +/- 8.1- 48.9 +/- 9.7 nmol TG/10(6) cells.2h). Apparently, the cycle was continuous throughout the whole incubation period despite falling ATP levels, contracture (rounding up) of myocytes, as well as cessation of glycogenolysis after about 40 min incubation. The cellular content of glycerol-3-phosphate, known to control TG-fatty acid cycling, increased continuously and to the same extent throughout the 2 h incubation period. Futile energy consumption associated with TG-fatty acid cycling, amounted to approximately 30% of total cellular energy consumption for the whole incubation period. In conclusion, hypoxic glucose deprived rat myocytes show TG-fatty-acid cycling, even after cessation of glycogenolysis. The extent of cycling, and thus the energy cost associated with it, was not influenced by the initial level of TG in the myocytes. We propose that glycerol-3-phosphate needed to fuel the TG-fatty acid cycle after exhaustion of the glycolytic supply is derived from phospholipid degradation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433315     DOI: 10.1016/0022-2828(92)91099-q

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats.

Authors:  D M Ouwens; C Boer; M Fodor; P de Galan; R J Heine; J A Maassen; M Diamant
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

Review 2.  Myocardial fatty acid metabolism and cardiac performance in heart failure.

Authors:  Helena Tuunanen; Heikki Ukkonen; Juhani Knuuti
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

3.  Hypoxia-stimulated glycerol production from the isolated, perfused rat heart is mediated by non-adrenergic mechanisms.

Authors:  C A Wardle; R A Riemersma
Journal:  Basic Res Cardiol       Date:  1994 Jan-Feb       Impact factor: 17.165

Review 4.  Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.

Authors:  Marina Bayeva; Konrad Teodor Sawicki; Hossein Ardehali
Journal:  J Am Heart Assoc       Date:  2013-11-25       Impact factor: 5.501

5.  Supplement of Lipid Emulsion to Epinephrine Improves Resuscitation Outcomes of Asphyxia-Induced Cardiac Arrest in Aged Rats.

Authors:  Lijun Huang; Qiusheng Ren; Shenghui Yu; Ya Shao; Yijun Chen; Xin Huang
Journal:  Clin Interv Aging       Date:  2020-09-22       Impact factor: 4.458

6.  The β3 Adrenergic Receptor Antagonist L-748,337 Attenuates Dobutamine-Induced Cardiac Inefficiency While Preserving Inotropy in Anesthetized Pigs.

Authors:  Lars Rødland; Leif Rønning; Anders Benjamin Kildal; Ole-Jakob How
Journal:  J Cardiovasc Pharmacol Ther       Date:  2021-09-23       Impact factor: 2.457

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.